Gastrointestinal Cancer Program investigators conduct ongoing research about a wide range of cancers that affect the gastrointestinal system, including pancreas, liver, esophagus and colon cancers, among others.
Researchers in medical and radiation oncology, medical genetics, pathology, surgery and many other specialties work together through the Gastrointestinal Cancer Program to gain a better understanding of the nature of cancer to give people with cancer of the gastrointestinal tract and biliary system the widest possible range of treatment options.
Scientists conduct laboratory-based research, studying cancer cells and the biological mechanisms within those cells to better understand the origin and growth of cancer. Other researchers engage in population science or epidemiology research, examining large groups of individuals to find patterns of risk for specific cancers.
Clinical trials test the most promising discoveries to determine the benefits for patients and compare new treatments with today's standard of care. Many of these clinical trials are the result of translational research, which involves researchers and clinicians determining how laboratory results may be applied to benefit patients diagnostically and therapeutically.
The Gastrointestinal Cancer Program has two co-leaders: